AAV8-RS1

N/A

Report date: 2023/10/26 16:40:20

Base Information

Drug NameAAV8-RS1
Drug Alias NameAAV8 scRS/IRBP hRSscAAV8/IRBP hRSscAAV8-hRs-IRBPAAV8-scRS/IRBP-hRS1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vector
Mechanisms of ActionRetinoschisin stimulantsGene transference
TargetsRetinoschisin
Therapy Area/IndicationsRetinoschisis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesVegaVect IncNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsRetinoschisis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A